SNZZF Stock Senzime AB (SNZZF, $0.65) was a top loser this week, declining -7.14%
at Tickeron.com
Loading...
Senzime AB (SNZZF, $0.65) was a top weekly loser, falling to $0.65 per share. Of the 223 stocks analyzed in the Medical/Nursing Services Industry throughout the week of October 10/13/2025 - 10/20/2025, 2025, of them (7) exhibited an Uptrend while of them (2) were in a Downtrend.
Momentum Indicator for SNZZF turns negative, indicating new downward trend
SNZZF saw its Momentum Indicator move below the 0 level on November 14, 2025. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 28 similar instances where the indicator turned negative. In of the 28 cases, the stock moved further down in the following days. The odds of a decline are at .
Technical Analysis (Indicators)
Bearish Trend Analysis
The Moving Average Convergence Divergence Histogram (MACD) for SNZZF turned negative on November 14, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 22 similar instances when the indicator turned negative. In of the 22 cases the stock turned lower in the days that followed. This puts the odds of success at .
The Aroon Indicator for SNZZF entered a downward trend on November 18, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Bullish Trend Analysis
The RSI Indicator shows that the ticker has stayed in the oversold zone for 21 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an Uptrend is expected.
Fundamental Analysis (Ratings)
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.476) is normal, around the industry mean (63.027). P/E Ratio (0.000) is within average values for comparable stocks, (35.851). SNZZF's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.651). SNZZF has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.019). P/S Ratio (8.576) is also within normal values, averaging (60.827).
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. SNZZF’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. SNZZF’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.
Advertisement
General Information
Industry MedicalNursingServices